Valeritas Holdings, Inc., the medical tech seller behind the V-Go wearable insulin delivery device, reached a settlement with creditors over its proposed $23 million sale to Zealand Pharma A/S, allowing the company to move ahead with a bankruptcy auction March 17.
U.S. Bankruptcy Court Judge Laurie Selber Silverstein said Friday she would approve the company’s bidding procedures and expedited timeline as a result of the settlement, which the company reached with a committee of unsecured creditors just minutes before the hearing in Wilmington, Del.
The unsecured creditors had objected to the sale process, saying it was happening too fast and ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
